Skip to main content
Premium Trial:

Request an Annual Quote

David Daly

Foundation Medicine has appointed David Daly as chief commercial officer. He was most recently vice president of commercial operations in the Anatomic Pathology Division at Thermo Fisher Scientific. Before that, he was head of oncology, medical sciences at Life Technologies, before the company was acquired by Thermo Fisher. Daly also held several positions at Clarient, including as chief commercial officer, and before that he worked in sales and marketing at Roche Diagnostics and Abbott Laboratories.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.